RAGHX — AllianzGI Health Sciences Fund
Data updated: 2026-09-11
RAGHX — AllianzGI Health Sciences Fund. United States Large Cap Blend / Core Health Care Equity · $91.70M AUM. Holdings, fees, performance and SEC filings.
RAGHX Fund Overview
RAGHX — AllianzGI Health Sciences Fund is a US mutual fund managed by Virtus Investment Trust, categorised as United States Large Cap Blend / Core Health Care Equity. ABC INVEST provides holdings, performance, costs, cashflows, risk data, prospectus documents and SEC filings, sourced from SEC filings.
- Type: US mutual fund
- Manager: Virtus Investment Trust
- Category: United States Large Cap Blend / Core Health Care Equity
- Assets under management: $91.70M
- 1-year return: 9.3%
- Ticker: RAGHX
- SEC CIK: 0000867297
- SEC series ID: S000007977
- Share class ID: C000021683
RAGHX Holdings
Top 10 holdings of AllianzGI Health Sciences Fund by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets |
|---|---|
| Eli Lilly & Company | 14.84% |
| West Pharmaceutical Services, Inc. | 5.92% |
| Abbvie, Inc. | 5.52% |
| Vertex Pharmaceuticals, Inc. | 5.32% |
| Merck & Company, Inc. | 5.06% |
| Unitedhealth Group, Inc. | 4.65% |
| Mckesson Corp. | 4.57% |
| Mettler-Toledo International, Inc. | 3.99% |
| Intuitive Surgical, Inc. | 3.89% |
| Amgen, Inc. | 3.85% |
RAGHX Portfolio Allocation
Asset-class allocation of AllianzGI Health Sciences Fund by percentage of net assets, from the latest SEC N-PORT filing.
| Asset class | Allocation |
|---|---|
| Equity | 98.5% |
RAGHX Performance
Total returns for RAGHX (as of 2026-09-01), from SEC filings.
| Period | Total return |
|---|---|
| YTD | -3.1% |
| 1 year | 9.3% |
| 3 years (annualised) | -28.2% |
| 5 years (annualised) | -37.7% |
RAGHX Risk Information
Risk metrics for RAGHX, derived from monthly returns in SEC filings.
- 1-year volatility (annualised): 17.3%
RAGHX Costs and Fees
RAGHX costs about $140 per $10,000 invested per year in fund expenses.
- Net expense ratio: 1.40%
- Gross expense ratio: 1.40%
- Portfolio turnover: 8%
- Brokerage commissions: 1.20 bps of average net assets (SEC N-CEN)
RAGHX Cashflows
Over the 12 months to 2026-06, AllianzGI Health Sciences Fund had net outflows of $20.71M, from monthly SEC N-PORT filings.
| Month | Net flow |
|---|---|
| 2026-06 | −$1.47M |
| 2026-05 | −$921.10K |
| 2026-04 | −$1.45M |
| 2026-03 | −$1.67M |
| 2026-02 | −$1.51M |
| 2026-01 | −$1.56M |
RAGHX Debt Constituents
No individual debt constituents are reported in AllianzGI Health Sciences Fund's latest SEC N-PORT filing.
RAGHX Prospectus and SEC Filings
Official AllianzGI Health Sciences Fund filings on SEC EDGAR — prospectus, portfolio holdings and annual reports.
- Prospectus (485BPOS) — filed 2025-10-22
- Prospectus (485BPOS) — filed 2024-10-24
- Prospectus supplement (497) — filed 2024-03-25
- Portfolio holdings (N-PORT) — filed 2026-08-28
- Portfolio holdings (N-PORT) — filed 2026-05-29
- Portfolio holdings (N-PORT) — filed 2026-02-26
- Annual census (N-CEN) — filed 2026-09-11
- Annual census (N-CEN) — filed 2025-09-12
Related Funds
Other United States Large Cap Blend / Core Health Care Equity funds tracked on ABC INVEST:
Data Sources
ABC INVEST compiles this page from public filings made to the U.S. Securities and Exchange Commission (SEC) through EDGAR: portfolio holdings and monthly cashflows from Form N-PORT, expenses and returns from fund prospectuses (Form 485BPOS) and the SEC DERA Risk/Return Summary data sets, annual data from Form N-CEN, and shareholder reports from Form N-CSR.